Insider trade

Stereotaxis (STXS): Director bought ~$25K

David Benfer, Director at Stereotaxis, bought ~$25K of Stereotaxis shares.

~$25K
Approx. value · 30K sh @ $0.829
240K
Holds after · shares reported
Traded
Nov 17, 2026
Filed
Nov 19, 2026

What stands out in this filing

  • 3 STXS insiders bought within the same week. That happened 7 times before in filings since 2006, most recently May 2012.
  • David Benfer's largest purchase of STXS in their filings since 2006.
  • David Benfer's first purchase of STXS since Mar 2015.
  • The purchase added 14.3% to the shares this insider held before it; the filing reports 240,255 shares, held indirectly afterwards.
  • 30,000 shares at an average of $0.829 each, as reported on the form.
  • No other open-market purchase by this insider in 20 months of filings.
  • 2 other insiders at STXS also bought in the open market within 30 days.

Calculated by OQRO from this filing and the public records it holds. Facts about the record, not a reason for the trade and not a signal.

The story around this disclosure

Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.

  1. Nov 9, 2026Company filing · Form 8-K · Material agreement, ResultsSigned an important agreement, and reported its results (and 2 more items)
  2. Nov 12, 20265% stakeDr. Nathan Fischel filed an activist stake (13D) of 15.3%
  3. Nov 16, 2026Insider · First insider buy since Mar 2025Director purchased ~$11K of STXS shares in the open market
  4. Nov 17, 2026 · this disclosureInsider · 3 insiders in a week, 8th time since 2006Director purchased ~$25K of STXS shares in the open market

What came next

  1. Nov 17, 2026Insider · 2 peopleInsiders: 2 purchases (~$100K)
View the official recordSEC Form 4

How to read SEC Form 4

Form 4 is the filing that officers, directors and owners of more than 10% of a US-listed company must send to the SEC within two business days after they buy, sell or otherwise change their holding of the company's stock.

Full guide: What is an SEC Form 4?

What else is on file for Stereotaxis

For Stereotaxis, OQRO holds 4 insider filings (SEC Form 4 or Form 144) and 1 fund holdings report (13F) dated in the last 90 days.

These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its STXS page.

How this filing works

Explore the data

Common questions

Which Stereotaxis (STXS) insider traded, and how much?

David Benfer, Director at Stereotaxis, bought ~$25K of Stereotaxis shares. 30K shares at $0.83, open market.

When did it happen, and when was it made public?

Traded: Nov 17, 2026. Filed: Nov 19, 2026. That is 2 days between the two dates.

What stands out in this filing?

3 STXS insiders bought within the same week. That happened 7 times before in filings since 2006, most recently May 2012. David Benfer's largest purchase of STXS in their filings since 2006. David Benfer's first purchase of STXS since Mar 2015.

Is the dollar amount exact?

It is the number of shares multiplied by the price the insider reported on the form. A grant, a gift or an option exercise has no market price, so those show shares only.

Where does this information come from?

From the SEC Form 4, a public record. The link to the official record is on this page, and OQRO copies its figures without changing them.

What else has been disclosed about Stereotaxis recently?

For Stereotaxis, OQRO holds 4 insider filings (SEC Form 4 or Form 144) and 1 fund holdings report (13F) dated in the last 90 days. They are listed on the STXS page.

Does this mean STXS stock is a buy or a sell?

No. This page describes one public filing. A filing does not say why someone traded and is not a forecast, so OQRO gives no recommendation.

Is OQRO free?

Yes. Every page of OQRO is free with an account, which takes a minute with Google and needs no card. Only the AI assistant is paid.

Other disclosures at Stereotaxis

Everything OQRO holds on this company is on its STXS page.

This is one filing. OQRO holds the rest

Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.

OQRO is free for everyone. No card, no trial

OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data